glp-1 kidney side effects Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy Exploring the Side Effects of
Description
Maintaining weight loss after stopping GLP-1 medications can be challenging
Journal of Clinical Gastroenterology
Consumer insights professionals should use this opportunity to prepare themselves not only for future GLP-1 growth but also for future health and weight loss trends
2016;6(Suppl 1):S32S36
This rapid and significant decline in muscle mass while taking GLP- 1 RA places certain patient populations already predisposed to sarcopenia at higher risk for muscle loss and adverse events
